MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-KL-11-0000399
Kannikkatt Pharmaceuticals Private Limited
Kannikkatt Pharmaceuticals Private Limited - pharma in Kottayam, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2026
₹26.09 Lakh
▲ 41% YoY
Net loss · FY 2026
₹32,607
Net margin -1.2%
EBITDA · FY 2026
-₹18,760
EBITDA margin -0.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
30 yrs
Est. 1996
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Kannikkatt Pharmaceuticals Private Limited
Data last updated:
Kannikkatt Pharmaceuticals Private Limited is a private limited company based in Kottayam, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 March 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24231KL1996PTC010177. Its GSTIN is 32AAACK9036D1ZX (Kerala).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Kannikkat Mathew Jose (Managing Director) and Jose Daisy.
Its last annual general meeting (AGM) was held on 30 June 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Building No. Kmc Xiv/360C Kannikkatt Buildings Kodimatha. P.O., Kottayam, Kerala, India – 686039.
As per the financials filed for FY 2026, the company reported a revenue of ₹26.09 Lakh, a growth of 41% compared to the previous year. For the same year it recorded a net loss of ₹32,607 (net margin -1.2%) and EBITDA of -₹18,760 (EBITDA margin -0.7%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 13% over five years.
Kannikkatt Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-11-0000399). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24231KL1996PTC010177
Registration Number 010177
Incorporation Date 20 March 1996
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 June 2026
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KL-11-0000399
Recognitions & Rankings of Kannikkatt Pharmaceuticals
Contact details
Kannikkatt Pharmaceuticals Private Limited's registered office is in Kottayam, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBuilding No. Kmc Xiv/360C Kannikkatt Buildings Kodimatha. P.O., Kottayam, Kerala, India – 686039
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kannikkatt Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Kannikkatt Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Kannikkatt Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Kannikkatt Pharmaceuticals Private Limited, buy the company report.
Financials of Kannikkatt Pharmaceuticals Private Limited
FY 2026 filings availableKannikkatt Pharmaceuticals Private Limited reported revenue of ₹26.09 Lakh (up 41% YoY) for FY 2026.
Revenue · FY 2026
₹26.09 Lakh ▲ 41%
Net loss · FY 2026
₹32,607 margin -1.2%
EBITDA · FY 2026
-₹18,760 margin -0.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 41%
3 years · compounded
▲ 11%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▼ 603%
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 41% growth in the latest year. EBITDA fell 603% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹26.09 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹18,760 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹32,607 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.7% | ||||
| Net Profit Margin | -1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kannikkatt Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kannikkatt Pharmaceuticals Private Limited
Kannikkatt Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kannikkat Mathew Jose | Managing Director | 20 Mar 1996 | 30 Years 7 Months | Current |
| Jose Daisy | Director | 29 Jul 2009 | 17 Years 3 Months | Current |
| Alka Jose | Director | 29 Jul 2009 | 17 Years 3 Months | Current |
Auditor
Kannikkatt Pharmaceuticals Private Limited is audited by AYYAR AND CHERIAN CHARTERED ACCOUNTANTS for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AYYAR AND CHERIAN CHARTERED ACCOUNTANTS | FY 2026 | 000284S |
Shareholding
The shareholding of Kannikkatt Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kannikkatt Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kannikkatt Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kannikkatt Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kannikkatt Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAACK9036D1ZX | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Kannikkatt Pharmaceuticals Private Limited, buy the company report.
Recent activity
Kannikkatt Pharmaceuticals Private Limited has 8 board changes on record since 1996: 3 appointments and 5 cessations. The latest: Joy Kurian ceased to be Additional Director on 31 Oct 2012.
AGM
Kannikkatt Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Jun 2026 as per latest MCA records.
Filing
Kannikkatt Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Ernakulam.
Ceased
Joy Kurian ceased to be Additional Director.
Ceased
Arun Jose ceased to be Director.
Ceased
Vini Paul ceased to be Director.
Appointed
Alka Jose was appointed as Director.
Appointed
Jose Daisy was appointed as Director.
Ceased
Kannikkatt Mathew Francis ceased to be Director.
Ceased
Kannikkatt Mathew George ceased to be Director.
Appointed
Kannikkat Mathew Jose was appointed as Managing Director.
Incorporation
20 Mar 1996
Kannikkatt Pharmaceuticals Private Limited was registered on 20 Mar 1996 with Roc Ernakulam & aged 30 years 7 months as per MCA records.
Frequently asked questions
Kannikkatt Pharmaceuticals is an active private limited company based in Kottayam, Kerala, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 March 1996 (30+ years old) and is registered under CIN U24231KL1996PTC010177.
Kannikkatt Pharmaceuticals has 3 current directors:
- Kannikkat Mathew Jose - Managing Director
- Jose Daisy - Director
- Alka Jose - Director
The latest financial statements of Kannikkatt Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 June 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Kannikkatt Pharmaceuticals is 32AAACK9036D1ZX, registered in Kerala.
The CIN (Corporate Identification Number) of Kannikkatt Pharmaceuticals is U24231KL1996PTC010177. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kannikkatt Pharmaceuticals was incorporated on 20 March 1996, making it 30+ years old. It is registered with the Registrar of Companies, Ernakulam.
Joy Kurian ceased to be Additional Director on 31 Oct 2012. Arun Jose ceased to be Director on 01 Apr 2011. Vini Paul ceased to be Director on 01 Apr 2011. Kannikkatt Pharmaceuticals has 8 board changes on record in total.
Yes, Kannikkatt Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-11-0000399).
The registered office of Kannikkatt Pharmaceuticals is at Building No. Kmc Xiv360C Kannikkatt Buildings Kodimatha. P.O., Kottayam, Kerala, India – 686039.
Kannikkatt Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages